Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for United Orthopedic Corporation (4129:TWSE), powered by AI.
United Orthopedic Corporation is currently trading at $90.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for United Orthopedic Corporation on Alpha Lenz.
View United Orthopedic Corporation's valuation metrics on Alpha Lenz.
“United Orthopedic Corporation's ROE is 14.1%. Explore profitability and growth together.”
Ask for details →United Orthopedic Corporation is a global manufacturer specializing in advanced orthopedic medical devices, primarily focusing on innovative hip and knee replacement implants and surgical instrument sets. Since its founding in 1993 and headquartered in Hsinchu, Taiwan, the company has established itself as a leading designer and producer in the health technology sector, with a product portfolio supporting both primary and revision joint replacement surgeries. United Orthopedic integrates research and development with advanced manufacturing, ensuring versatile, high-quality solutions tailored to meet the needs of surgeons and improve patient outcomes. Its reach extends to over 50 countries, where its award-winning products and customer support have made a substantial impact on healthcare institutions, practitioners, and patients seeking reliable orthopedic solutions. Beyond clinical innovation, United Orthopedic plays a critical role in elevating global standards of joint mobility and quality of life for individuals suffering from degenerative orthopedic conditions, reinforcing its position as a trusted partner in the medical specialties industry.
“United Orthopedic Corporation's ROE is 14.1%. Explore profitability and growth together.”
Ask for details →United Orthopedic Corporation (ticker: 4129) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 90.9 with a P/E ratio of -x and P/B of -x.
ROE is 14.15% and operating margin is 13.03%. Annual revenue is $5.7B.